Autophagy Modulation in Lymphocytes From COVID-19 Patients: New Therapeutic Target in SARS-COV-2 Infection

Autophagy Modulation in Lymphocytes From COVID-19 Patients: New Therapeutic Target in SARS-COV-2 Infection

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the novel coronavirus, causing coronavirus disease 2019 (COVID-19). During virus infection, several pro-inflammatory cytokines are produced, leading to the “cytokine storm.” Among these, interleukin (IL)-6, tumor necrosis factor‐α (TNF‐...

Full description

Bibliographic Details
Main Authors: Marta Vomero, Cristiana Barbati, Tania Colasanti, Alessandra Ida Celia, Mariangela Speziali, Federica Maria Ucci, Claudia Ciancarella, Fabrizio Conti, Cristiano Alessandri
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Pharmacology
Subjects:
SARS-CoV-2
CoViD-19
autophagy
lymphocytes
cytokines
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2020.569849/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2020.569849/full

Similar Items